Genmont Biotech In 

TWD17.9
2
-TWD0.1-0.56% Wednesday 05:30

Statistics

Day High
18.3
Day Low
17.7
52W High
21.35
52W Low
17.55
Volume
65,926
Avg. Volume
-
Mkt Cap
1.54B
P/E Ratio
27.2
Dividend Yield
3.35%
Dividend
0.6

Upcoming

Dividends

3.35%Dividend Yield
May 26
TWD0.2
May 26
TWD0.6
Apr 25
TWD0.8
Jul 24
TWD0.23
Jul 23
TWD0.7
10Y Growth
N/A
5Y Growth
1.04%
3Y Growth
-5.01%
1Y Growth
-25%

Earnings

29MayExpected
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q1 2024
0.09
0.18
0.27
0.35
Expected EPS
N/A
Actual EPS
N/A

Financials

14.86%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
770.75MRevenue
114.5MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 3164.TW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Taiwan Semiconductor Manufacturing
2330.TW
Mkt Cap52.64T
Taiwan Semiconductor Manufacturing Co. (TSMC) is a major player in the semiconductor industry, providing essential components that could be used in biotech instrumentation.
Novatek Microelectronics
3034.TW
Mkt Cap252.84B
NovaTek engages in the manufacturing of display components, which are crucial for biotech devices, making them a direct competitor in the biotech supply chain.
Nan Ya Plastics
1303.TW
Mkt Cap701.08B
Nan Ya Plastics Corporation produces plastic materials, some of which are used in biotech applications, competing in the biotech ancillary market.
Hon Hai Precision Industry
2317.TW
Mkt Cap2.88T
Hon Hai Precision Industry, also known as Foxconn, has ventures in health technologies and medical devices, positioning them as a competitor in the biotech field.
Cathay Financial
2882.TW
Mkt Cap1.1T
Cathay Financial Holding Co., Ltd. invests in a broad range of industries including biotech, potentially competing for the same investment and resources.
China Steel
2002.TW
Mkt Cap304.11B
China Steel Corporation supplies materials that are essential in manufacturing various biotech equipment, indirectly competing in the biotech industry.
CTBC Financial
2891.TW
Mkt Cap1.04T
CTBC Financial Holding Co., Ltd. also invests in healthcare and biotech sectors, competing for market share and investments.
Fubon Financial.
2881.TW
Mkt Cap1.23T
Fubon Financial Holding Co. is involved in investment activities in the biotech sector, competing in financial and resource allocation aspects.
United Micro Electronics
2303.TW
Mkt Cap918.94B
United Microelectronics Corporation (UMC) manufactures products for multiple sectors including biotech, providing essential technology and competing in market share.
Asustek Computer
2357.TW
Mkt Cap444.91B
Asustek Computer Inc. ventures into healthcare solutions, including biotech-related technologies, making them a competitor in innovative biotech solutions.

About

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.
Show more...
CEO
Country
Taiwan
ISIN
TW0003164000

Listings

0 Comments

Share your thoughts

FAQ

What is Genmont Biotech In stock price today?
The current price of 3164.TW is TWD17.9 TWD — it has decreased by -0.56% in the past 24 hours. Watch Genmont Biotech In stock price performance more closely on the chart.
What is Genmont Biotech In stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genmont Biotech In stocks are traded under the ticker 3164.TW.
Is Genmont Biotech In stock price growing?
3164.TW stock has fallen by -0.56% compared to the previous week, the month change is a -0.56% fall, over the last year Genmont Biotech In has showed a -7.01% decrease.
What is Genmont Biotech In market cap?
Today Genmont Biotech In has the market capitalization of 1.54B
What is Genmont Biotech In revenue for the last year?
Genmont Biotech In revenue for the last year amounts to 770.75M TWD.
What is Genmont Biotech In net income for the last year?
3164.TW net income for the last year is 114.5M TWD.
Does Genmont Biotech In pay dividends?
Yes, 3164.TW dividends are paid annual. The last dividend per share was 0.8 TWD. As of today, Dividend Yield (FWD)% is 3.35%.
In which sector is Genmont Biotech In located?
Genmont Biotech In operates in the Health & Wellness sector.
When did Genmont Biotech In complete a stock split?
The last stock split for Genmont Biotech In was on June 15, 2010 with a ratio of 1.05:1.
Where is Genmont Biotech In headquartered?
Genmont Biotech In is headquartered in Tainan City, Taiwan.